1. AB0207 Change in anti-citrullinated protein autoantibody levels in clinical practice are associated with resource use and disease activity measures. (15th June 2017) Authors: Alemao, E; Guo, Z; Iannaccone, C; Frits, M; Shadick, N; Weinblatt, M Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0208 Hospitalization rates in patients with ra by poor prognostic factors: impact of abatacept and other disease-modifying antirheumatic therapies. (15th June 2017) Authors: Alemao, E; Burns, L; Guo, Z Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0397 Abatacept shows better sustainability than tnf inhibitors when used following initial biologic dmard failure in the treatment of rheumatoid arthritis: 8 years of real-world observations from the rhumadata® clinical database and registry. (15th June 2017) Authors: Choquette, D; Bessette, L; Alemao, E; Haraoui, B; Massicotte, F; Mtibaa, M; Muratti, E; Pelletier, J-P; Postema, R; Raynauld, J-P; Rémillard, M-A; Sauvageau, D; Turcotte, A; Villeneuve, Έ; Coupal, L Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0408 Comparative effectiveness of abatacept versus tnfi in patients with rheumatoid arthritis who are ccp+ in the united states corrona registry. (15th June 2017) Authors: Harrold, L; Litman, H; Connolly, S; Alemao, E; Price, K; Kelly, S; Rebello, S; Hua, W; Kremer, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB1143 The impact of anti-cyclic citrullinated peptide seropositivity on erosion prevalence among patients with rheumatoid arthritis of varying disease duration. (15th June 2017) Authors: Harrold, L; Price, K; Litman, H; Connolly, S; Alemao, E; Rebello, S; Hua, W; Kremer, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1455 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0223 Anti-ccp is an independent predictor of 12-month eular response in patients with ra treated with abatacept. (15th June 2017) Authors: Broeder, A den; Kerstens, T; Fransen, J; Ende, C van den; Tweehuysen, L; Postema, R; Alemao, E; Hoogen, F van den Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 568 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0230 Retention rates of tnf inhibitors and abatacept used as a first biologic dmard in the treatment of rheumatoid arthritis: 8 years of experience from the rhumadata® registry. (15th June 2017) Authors: Choquette, D; Bessette, L; Alemao, E; Haraoui, B; Massicotte, F; Mtibaa, M; Muratti, E; Pelletier, J-P; Postema, R; Raynauld, J-P; Rémillard, M-A; Sauvageau, D; Turcotte, A; Villeneuve, Έ; Coupal, L Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0232 Treatment effects of abatacept and anti-tnf in patients with ra with poor prognostic factors: data from community rheumatology clinics. (15th June 2017) Authors: Alemao, E; Knapp, K; Anupindi, V; Annamalai, S; Craig, G Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 572 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0499 Real-world study on the patterns and cost of treatment failure in patients with psoriatic arthritis using us claims data. (15th June 2017) Authors: Price, K; Alemao, E; Burns, L; Guo, Z; Anupindi, V; Goday, S Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0520 Improved patient-reported outcomes in psoriatic arthritis patients treated with abatacept: results from a phase iii trial. (15th June 2017) Authors: Strand, V; Alemao, E; Lehman, T; Johnsen, A; Banerjee, S; Ahmad, H; Mease, P Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗